# Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

> clinical trial · VERIFIED · 2026-09-02

Status: RECRUITING · Sponsor: University Hospital, Geneva · Condition: Coronary Artery Disease

- Company: University Hospital, Geneva
- Sector: cardiology
- Primary source: https://clinicaltrials.gov/study/NCT06710210

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.